Cash Return On Invested Capital (CROIC)

The following section summarizes insights on 's Cash Return On Invested Capital (CROIC):

• Merck's latest twelve months buyback yield is 0.5%
• Merck's buyback yield for fiscal years ending December 2020 to 2024 averaged 0.3%.
• Merck's operated at median buyback yield of 0.4% from fiscal years ending December 2020 to 2024.
• Looking back at the last 5 years, Merck's buyback yield peaked in December 2020 at 0.6%.
• Merck's buyback yield hit its 5-year low in December 2022 of -0.1%.
• Merck's buyback yield decreased in 2020 (0.6%, -69.8%), 2021 (0.3%, -42.8%), and 2022 (-0.1%, -141.4%) and increased in 2023 (0.4%, -423.8%) and 2024 (0.5%, +15.4%).